Literature DB >> 32989416

Surveys on COVID-19 in nuclear medicine: what happened and what we learned.

Salvatore Annunziata1, Domenico Albano2, Riccardo Laudicella3, Matteo Bauckneht4.   

Abstract

INTRODUCTION: To summarize and comment the available surveys on the impact of COVID-19 on Nuclear Medicine (NM) departments.
METHODS: Recent surveys about the impact of COVID-19 on Nuclear Medicine (NM) departments have been searched on available scientific database.
RESULTS: Three surveys have been found and commented. Some differences among the surveys should be kept in mind. All studies agreed that COVID-19 had a relevant impact on NM departments.
CONCLUSION: Surveys about the impact of COVID-19 in NM could improve the departments' daily activities, to find a compromise between the security protocols suggested by international guidelines. © Italian Association of Nuclear Medicine and Molecular Imaging 2020.

Entities:  

Keywords:  COVID; Nuclear Medicine; Survey

Year:  2020        PMID: 32989416      PMCID: PMC7512213          DOI: 10.1007/s40336-020-00391-z

Source DB:  PubMed          Journal:  Clin Transl Imaging        ISSN: 2281-5872


COronaVIrus Disease 19 (COVID-19) is still spreading worldwide, and the pandemic peak has probably not been reached yet. During the pandemic, Nuclear Medicine (NM) departments have been involved in several changes and issues, such as new scheduling praxes for NM diagnostic and therapeutic procedures, the assistance of patients with diagnosed or suspected COVID-19, and the prevention of COVID-19 spreading in the departments. For these reasons, some research groups promoted different international surveys to understand the impact of the pandemic on NM departments [1-3]. The Young Group of the Italian Association of Nuclear Medicine (AIMN) developed the first international survey to evaluate the impact of COVID-19 in NM and performed a preliminary report of the obtained responses [1]. Two-hundred and ninety-six individual responders from 220 departments were evaluated. Most of the responders were from Europe (67%). Approximately, all departments changed their scheduling praxes due to the pandemic (97%). In most departments, scheduled diagnostic and therapeutic procedures were allowed but quantitatively reduced (51%). A significant reduction (more than 20%) of diagnostic and therapeutic procedures affected 90% and 72% of the departments, respectively. Incidental COVID-19 signs in NM exams occurred in about half of the departments. Only a few departments were closed or shifted to assist patients with COVID-19 (16%). Finally, most of the responders thought that the pandemic would not permanently change the work of NM departments in the future (64%) [1]. Another international research group promoted a survey about the global impact of COVID-19 on NM departments [2]. A total of 434 responses from 72 countries were registered and analysed. The authors reported an average decline of 54% in diagnostic procedures. Namely, PET/CT scans decreased by an average of 36%, sentinel lymph-node procedures decreased by 45%, lung scans by 56%, bone scans by 60%, myocardial studies by 66%, and thyroid studies by 67%. About radionuclide therapies, they reported a reduction of 45%, ranging from over 76% in Latin America and Asiatic South-East to 16% in South Korea and Singapore. Survey results showed that 52% of the participating sites limited their 99mTc/99Mo generator purchases, and 12% of them temporarily canceled orders. Insufficient supplies of essential materials (radioisotopes, generators, and kits), especially for 99mTc/99Mo generators and 131I, were mainly reported in Africa, Asia, and Latin America [2]. The same research group promoted a regional analysis of the impact of COVID-19 on NM in Germany, Austria, and Switzerland [3]. In this survey, 113 complete responses were recorded. Nearly, all participants reported a decline of NM diagnostic procedures. The mean reduction for PET/CT, scintigraphy of bone, myocardium, lung, thyroid, sentinel lymph-node was of 14%, 47%, 48%, 41%, 58%, and 25%, respectively. Furthermore, 76% of the participants reported a reduction in therapeutic procedures, mainly for benign thyroid disease (42%) and radiosynoviorthesis (54%), while tumor therapies remained almost stable. Also, half of the participants reported a shortage of staff’s protective equipment [3]. A summary of the results from the three surveys is reported in Table 1.
Table 1

Comparison of the mains results emerging by the three recent surveys performed about the impact of COVID-19 pandemic on NM departments in different countries worldwide

Authors, [ref]Journal nameReduction of NM procedures (%)
Conventional scintigraphyPETTherapy
Annunziata et al. [1]Eur J Nucl Med Mol Imaging70a11a19a
Freudenberg et al. [2]J Nucl Med54b36b45b
Freudenberg et al. [3]Nuklearmedizine40b14b30b

NM nuclear medicine, COVID-19 COronaVIrus Disease 19

aWorst reduction over the total of the responders

bMean reduction among the responders

Comparison of the mains results emerging by the three recent surveys performed about the impact of COVID-19 pandemic on NM departments in different countries worldwide NM nuclear medicine, COVID-19 COronaVIrus Disease 19 aWorst reduction over the total of the responders bMean reduction among the responders Some limitations and differences among these three surveys should be kept in mind: the structure of the questionnaires, the methods used to invite the participants, the number of responses from the same department, and the discrepancies due to geographical criteria and pandemic stages. Nevertheless, all the three studies agreed that COVID-19 had a relevant impact on NM departments in the scheduling praxes for diagnostic and therapeutic procedures, the assistance of patients with diagnosed or suspected COVID-19, and the prevention of COVID-19 spreading in the departments. The decrease and/or the postponement of medical procedures underlined that potentially many patients have been “missed” during the pandemic, and this may impact on the disease’s clinical course, potentially affecting also the quality of life and survival, opening an ethical debate. Namely, according to the global survey by Freudenberg et al. [2], it is unknown whether the decrease in the NM procedures is attributable to patients’ fears and preferences, safety precautions adopted by NM centers, disruption of supply chains and logistical challenges, or a combination of all the above [2]. Nevertheless, some suggestions for future actions could be derived from all these studies as: awareness of the main guidelines for the organization of the departments; scheduling of NM examinations considering urgency and appropriateness criteria; robust screening process as phone or on-site pre-triage; attention to simply rules (also hygienic), as proper distancing and escalation for suspected cases; further investigations for possible indications of NM examinations in the ordinary management of COVID-19 [1]. According to Freudenberg et al. [2], it is our responsibility to continue providing essential services to ascertain adequate diagnostic and therapeutic patient services, while ensuring proper hygienic measures, thus safeguarding the health of staff, patients and the public. It is also essential to address the significant disruptive economic impact of this pandemic on healthcare systems, with particular interest to NM departments. The more we know about the current and upcoming challenges, the better we can learn and adapt collectively to them [2]. For instance, the fruitful cooperation between different NM departments to provide a prompt radionuclide treatment to patients coming from different Italian regions should be underlined. The lesson we learned from this global experience should be useful to improve NM departments’ daily activities, to find a compromise between the security protocols suggested by international guidelines and the need to continue medical assistance in favor of the emergency needs without sacrificing patients’ healthcare.
  3 in total

1.  Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020.

Authors:  Lutz S Freudenberg; Ulf Dittmer; Ken Herrmann
Journal:  Nuklearmedizin       Date:  2020-04-28       Impact factor: 1.379

2.  Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey.

Authors:  Salvatore Annunziata; Matteo Bauckneht; Domenico Albano; Giovanni Argiroffi; Diletta Calabrò; Elisabetta Abenavoli; Flavia Linguanti; Riccardo Laudicella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-27       Impact factor: 9.236

3.  Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020.

Authors:  Lutz S Freudenberg; Diana Paez; Francesco Giammarile; Juliano Cerci; Moshe Modiselle; Thomas N B Pascual; Noura El-Haj; Pilar Orellana; Yaroslav Pynda; Ignasi Carrió; Stefano Fanti; Cristina Matushita; Ken Herrmann
Journal:  J Nucl Med       Date:  2020-07-24       Impact factor: 11.082

  3 in total
  5 in total

Review 1.  Global research trends in COVID-19 with MRI and PET/CT: a scoping review with bibliometric and network analyses.

Authors:  Nathaly Rivera-Sotelo; Raul-Gabriel Vargas-Del-Angel; Sergey K Ternovoy; Ernesto Roldan-Valadez
Journal:  Clin Transl Imaging       Date:  2021-08-14

Review 2.  Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review.

Authors:  Salvatore Annunziata; Roberto C Delgado Bolton; Christel-Hermann Kamani; John O Prior; Domenico Albano; Francesco Bertagna; Giorgio Treglia
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-10

3.  Impact of COVID-19 pandemic on 2-[18F]FDG PET/CT imaging work-flow in a single medical institution: comparison among the three Italian waves.

Authors:  Simone Maurea; Claudia Bombace; Ciro Gabriele Mainolfi; Alessandra Annunziata; Ludovica Attanasio; Arnaldo Stanzione; Elide Matano; Brigitta Mucci; Alessandro D'Ambrosio; Claudia Giordano; Mario Petretta; Silvana Del Vecchio; Alberto Cuocolo
Journal:  Heliyon       Date:  2022-01-22

4.  Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing 18F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes.

Authors:  Cristina Gamila Wakfie-Corieh; Federico Ferrando-Castagnetto; Alba María Blanes García; Marta García García-Esquinas; Aída Ortega Candil; Cristina Rodríguez Rey; María Nieves Cabrera-Martín; Ana Delgado Cano; José Luis Carreras Delgado
Journal:  J Nucl Med       Date:  2021-06-04       Impact factor: 10.057

5.  Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies.

Authors:  Marina Orevi; Alexandre Chicheportiche; Simona Ben Haim
Journal:  J Nucl Med       Date:  2021-07-22       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.